Skip to main content
TNYA
NASDAQ Life Sciences

Tenaya Q3 Loss Beats Estimates; $66.8M Cash Runs Into Q4 2027

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.377
Mkt Cap
$84.311M
52W Low
$0.351
52W High
$1.56
52W Position info
7.4% above low
Off High info
76% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

TNYA is trading near its 52-week low of $0.351 (7.4% above the low).

Summary

Tenaya posted an $18.94M Q3 net loss, or $0.08 per basic share, with an operating loss of $19.57M that came in better than the $22.67M consensus from three analysts. Operating expenses were $21.27M, helped by lower R&D spending including reduced stock-based compensation. Cash stood at $66.8M as of September 30, which management says funds operations into Q4 2027 — a long runway for a company this small. The quarter also carries the FDA's RMAT designation for TN-401, granted in September on positive interim RIDGE-1 data. Near-term news flow is defined: longer-term MyPEAK-1 follow-up and additional interim RIDGE-1 data are both expected by year end, with at least one Phase 2 TN-301 trial planned for H2 2027.

At the time of this announcement, TNYA was trading at $0.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $84.3M. The 52-week trading range was $0.35 to $1.56. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

TNYA - Latest Insights

TNYA
Nov 04, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.385
Real-time Price: $0.2939 info
Change: -$0.0911 (-24%) info
Market Cap: $65.324M info
TNYA
Oct 13, 2026, 4:42 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.530
Real-time Price: $0.2939 info
Change: -$0.2361 (-45%) info
Market Cap: $65.324M info
TNYA
Sep 14, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.6395
Real-time Price: $0.2939 info
Change: -$0.3456 (-54%) info
Market Cap: $65.324M info
TNYA
Aug 05, 2026, 4:46 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.7497
Real-time Price: $0.2939 info
Change: -$0.4558 (-61%) info
Market Cap: $65.324M info
TNYA
Jul 02, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7865
Real-time Price: $0.2939 info
Change: -$0.4926 (-63%) info
Market Cap: $65.324M info